Inactivating Mutations ofRB1andTP53Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors

Larissa Merten, Abbas Agaimy, Evgeny A. Moskalev, Johannes Giedl, Claudia Kayser, Helene Geddert, Inga‐Marie Schaefer, Silke Cameron, Martin Werner, Philip Ströbel, Arndt Hartmann, Florian HallerAmerican 2016 · DOI

Abstract

TP53 and RB1 mutations seem to be restricted to high-risk/malignant GISTs and occur at an equal although relatively low frequency.
BibTeX
@inproceedings{merten2016inactivating,
  author = {Larissa Merten and Abbas Agaimy and Evgeny A. Moskalev and Johannes Giedl and Claudia Kayser and Helene Geddert and Inga‐Marie Schaefer and Silke Cameron and Martin Werner and Philip Ströbel and Arndt Hartmann and Florian Haller},
  title = {{Inactivating Mutations of<i>RB1</i>and<i>TP53</i>Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors}},
  booktitle = {American},
  year = {2016},
  doi = {10.1093/ajcp/aqw193},
}

Loading related content...

Figure